Incidence of renal dysfunction over 6 months in patients with chronic heart failure due to left ventricular systolic dysfunction: contributing factors and relationship to prognosis

被引:170
作者
de Silva, R
Nikitin, NP
Witte, KKA
Rigby, AS
Goode, K
Bhandari, S
Clark, AL
Cleland, JGF
机构
[1] Univ Hull, Acad Dept Cardiol, Castle Hill Hosp, Kingston Upon Hull HU16 5JQ, N Humberside, England
[2] Hull & E Yorkshire NHS Trust, Dept Nephrol, Kingston Upon Hull, N Humberside, England
关键词
chronic heart failure; renal dysfunction;
D O I
10.1093/eurheartj/ehi696
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aims To determine the prevalence and incidence of renal dysfunction (RD) in patients with chronic heart failure (CHF), to identify contributory factors and predictors of worsening renal function (WRF), and to explore the relationship between RD and mortality. Methods and results Prospective data on 1216 patients with CHF were analysed. The glomerular filtration rate (GFR) was used to determine renal function, and WRF was defined as an increase in serum creatinine of > 26.5 mu mol/L (> 0.3 mg/dL). The prevalence of RD defined as a GFR of < 60 mL/min was 57%. During 6 months, WRF occurred in 161 (13.0%) patients. Predictors of WRF were vascular disease, the use of thiazide diuretics, and a baseline urea > 9 mmol/L. Two hundred and sixty-three (21.6%) patients died, and baseline RD and WRF both predicted a higher mortality (P < 0.001), whereas an improvement in renal function over the first 6 months predicted a lower mortality (hazard ratio 0.8, 95% confidence interval 0.6-1.0). Conclusion In ambulatory patients with CHF, RD is common, commonly deteriorates over a relatively short period of time, is unlikely to recover substantially, and augurs a poor prognosis.
引用
收藏
页码:569 / 581
页数:13
相关论文
共 73 条
[1]   Cause and management of heart failure in patients with chronic renal disease [J].
Al-Ahmad, A ;
Sarnak, MJ ;
Salem, DN ;
Konstam, MA .
SEMINARS IN NEPHROLOGY, 2001, 21 (01) :3-12
[2]  
Altman D., 2000, STAT CONFIDENCE
[3]  
[Anonymous], 2002, AM J KIDNEY DIS, V39, pS76
[4]  
[Anonymous], APPL STAT
[5]   Re-evaluation of risks associated with hyperphosphatemia and hyperparathyroidism in dialysis patients: Recommendations for a change in management [J].
Block, GA ;
Port, FK .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2000, 35 (06) :1226-1237
[6]   Biochemical and clinical evidence for uremic toxicity [J].
Bouré, T ;
Vanholder, R .
ARTIFICIAL ORGANS, 2004, 28 (03) :248-253
[7]   A QUANTITATIVE ASSESSMENT OF PLASMA HOMOCYSTEINE AS A RISK FACTOR FOR VASCULAR-DISEASE - PROBABLE BENEFITS OF INCREASING FOLIC-ACID INTAKES [J].
BOUSHEY, CJ ;
BERESFORD, SAA ;
OMENN, GS ;
MOTULSKY, AG .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1995, 274 (13) :1049-1057
[8]   SUBMODEL SELECTION AND EVALUATION IN REGRESSION - THE X-RANDOM CASE [J].
BREIMAN, L ;
SPECTOR, P .
INTERNATIONAL STATISTICAL REVIEW, 1992, 60 (03) :291-319
[9]   Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy [J].
Brenner, BM ;
Cooper, ME ;
de Zeeuw, D ;
Keane, WF ;
Mitch, WE ;
Parving, HH ;
Remuzzi, G ;
Snapinn, SM ;
Zhang, ZX ;
Shahinfar, S .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (12) :861-869
[10]   Influence of concomitant disease on patterns of hospitalization in patients with heart failure discharged from Scottish hospitals in 1995 [J].
Brown, AM ;
Cleland, JGF .
EUROPEAN HEART JOURNAL, 1998, 19 (07) :1063-1069